Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 19 of 23
Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects
NCT01617616
Advanced Image Guidance Utilized in Liver Surgery
NCT01666145
Pediatric Supracondylar Humerus Fracture NIRS Study
NCT01808183
Healing Touch or Guided Imagery In Treating Pain, Fatigue, Nausea, and Anxiety in Patients Undergoing Chemotherapy
NCT01553578
Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery
NCT01483196
Postoperative Pain and Skin Closure Methods After Cesarean Section
NCT02028000
Prediction of Methotrexate Response - A Pilot Study
NCT01726959
Limb Girdle Muscular Dystrophy (LGMD) Natural History
NCT01783509
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
NCT01595646
A Clinical Trial Using Spy Elite System in Planning Tissue Advancement Flaps After Ventral Hernia Repair
NCT01886963
Low Pain Prediction in Cesarean Section Patients
NCT02143141
A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary Obstruction
NCT01514058
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
NCT01434342
Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy
NCT01506440
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
NCT01407770
Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing
NCT01516125
Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder
NCT01430767
Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors
NCT01474174
A Prospective Study Evaluating The Utility of Transnasal Endoscopy With Roux en Y Gastric Bypass
NCT01526772
Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer
NCT01054079
HIRREM Developmental Study
NCT02709369
Prosocial Behavior and Volunteerism to Promote Physical Activity in Older Adults
NCT01528761
A Pilot Study of Intra-arrest Therapeutic Hypothermia in Patients Suffering Non-Traumatic Out of Hospital Cardiac Arrest
NCT01413399
Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis
NCT01815489
Remote Ischemic PreConditioning Effect on Postsurgical Pain
NCT01383317
Acupuncture in Menopause
NCT01276028
Title: Comparative Effectiveness of Asthma Interventions Within an AHRQ PBRN
NCT01280500
Use of a Soy-based Meal Replacement Weight Loss Intervention to Impact Ectopic Fat
NCT01298817
Dietary Intervention for Visceral Adiposity
NCT01350518
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
NCT01484015
The Effect of Hypovitaminosis D and Vitamin D Supplementation on Fracture Nonunion Rates
NCT01691833
Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
NCT01234922
Cryosurgery and Cream Combination for Actinic Keratosis
NCT03037541
Starting Pediatric Obesity Prevention in Pregnancy
NCT01279109
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
NCT01273766
Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD)
NCT01259596
Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer
NCT01457469
Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy
NCT01164566
Yoga Therapy in Treating Patients With Malignant Brain Tumors
NCT01234805
Effects of Swallowing Exercises on Patients Undergoing Radiation Treatment for Head and Neck Cancer
NCT01053546
L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors
NCT01105130
EUS Prior to ERCP in the Positive Setting of Positive Intraoperative Cholangiogram (IOC) During Cholecystectomy
NCT01525355
Improving Vitamin D Status in Home-bound Elders
NCT01410084
Electronic Medical Record Review in Monitoring the Effects of Adherence on Myelosuppression and Morbidity in Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide and Radiation Therapy
NCT02208336
Nitric Oxide, GeNO Nitrosyl Delivery System
NCT01165047
L-Carnitine Administration in Early Sepsis
NCT01193777
Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors
NCT01032200
Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer
NCT01185639
Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
NCT01151670
High Pain Intervention in Cesarean Sections
NCT01298778
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.